Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC4880 Srebp-in-dhg

Novel inhibitor of sterol regulatory element-binding protein (SREBP), impairing the SREBP activity by inhibiting glucose transporters and thereby activating AMP-activated protein kinase (AMPK)

DCC4881 Sri-22138

Novel mixed μ opioid receptor (MOR) agonist and δ/κ opioid receptor (DOR/KOR) antagonist

DCC4882 Sri-29132

Highly blood-brain barrier permeant, potent, and selective for LRRK2 kinase activity, being effective in attenuating pro-inflammatory responses in macrophages and rescuing neurite retraction phenotypes in neurons.

1482305-44-1
DCC4883 Sri-31040

Potent DAT allosteric modulator, partially inhibiting DAT uptake without altering DAT-mediated reverse transport and with minimal inhibition of DAT binding

1928715-72-3
DCC4884 Sri-35241

Novel inhibitor of thrombospondin 1 activation of TGF-β, blocking TGF-β activation (pIC50 = 8.12 nM) and has a plasma half life of 1.8 h (iv)

2307429-54-3
DCC4885 Sri-36160

Novel potent inhibitor of Wn/ß-catenin signaling in cancer cells

2085682-66-0
DCC4886 Sri-37683

Novel GLUT inhibitor, preferentially inhibiting the growth of GBM cells with minimal toxicity to non-neoplastic astrocytes and neurons, also inhibiting glucose uptake and decrease the glycolytic capacity and glycolytic reserve capacity of GBM patient-deri

DCC4887 Sri-37684

Novel GLUT inhibitor, preferentially inhibiting the growth of GBM cells with minimal toxicity to non-neoplastic astrocytes and neurons, also inhibiting glucose uptake and decrease the glycolytic capacity and glycolytic reserve capacity of GBM patient-deri

DCC4888 Sri-39067

Novel MOR agonist/DOR antagonist that produced systemically active potent antinociceptive activity in tail-flick assay in mice

DCC4889 Srt3025

Novel Sirtuin1 Activator, Down-Regulating Sclerostin and Rescuing Ovariectomy-Induced Bone Loss

1231952-55-8
DCC4890 Srt3025 Hydrochloride

Novel potent SIRT1 activator

2070015-26-6
DCC4891 Srt3190 (2s,3r)

Novel selective CXCR2 antagonist

1204707-73-2
DCC4892 Srta-in-i

Novel potent inhibitor of Staphylococcus aureus sortase A (SrtA)

DCC4893 Ss1020

Novel antiestrogen, lacking estrogenic and genotoxic actions

DCC4894 SS-amyloid-in-7l

Potent ß-amyloid aggregation inhibitor; Antioxidant

DCC4895 SS-carboline-1-carboxylic Acid

Potent competitive inhibitor of indoleamine 2,3-dioxygenase (IDO)

26052-96-0
DCC4896 SS-cit

Non-selective potent dopamine reuptake inhibitor

135416-43-2
DCC4897 SS-cit Tartrate

Non-selective potent dopamine reuptake inhibitor

133647-95-7
DCC4898 SS-elemene

Novel inhibitor of Pak1 activation, anti-cancer ingredient isolated from the Chinese traditional herb Curcuma wenyujin

33880-83-0
DCC4899 SS-hydroxymethyl Chalcone

The first selective inhibitor of Histone Deacetylase 2 (HDAC2)

1613310-15-8
DCC4900 Ssj-183

Novel antimalarial agent

1187533-34-1
DCC4901 SS-lysine

Elongation factor P (EF-P) fuction modifier

4299-56-3
Page 1444 / Total 1558 FirstPrevNextLastGoto